Trial Condition(s):
Epidemiologic factors
Patient characteristics in daily radiological practice of Gadovist® application (PATRON)
Bayer Identifier:
14317
ClinicalTrials.gov Identifier:
EudraCT Number:
Not Available
EU CT Number:
Not Available
Trial Purpose
To evaluate patient characteristics in the current daily radiological practice of Gadovist application. Special focus will be laid on the individual risk factors of patients, the indications for and the dose of Gadovist application.
Secondary objective is to prove the known safety profile (especially rare adverse events) of Gadovist and to collect data on handling problems with different application forms (one questionnaire per center).
Inclusion Criteria
- patients with indication for a MRT or MR-Angiography and for whom the radiologist has decided to use the contrast medium Gadovist
Exclusion Criteria
- No exclusion criteria besides the contraindications for the use of Gadovist as mentioned in the German product information.
Trial Summary
Enrollment Goal
Trial Dates
Phase
Could I receive a placebo?
Products
Accepts Healthy Volunteers
Where to Participate
| Locations | |
|---|---|
Locations Investigative Site Many Locations, Germany | Contact Us: E-mail: [email protected] Phone: Not Available |
Trial Design
Patient characteristics in daily radiological practice of Gadovist® application (PATRON)
Trial Type:
Observational
Intervention Type:
Biological/Vaccine
Trial Purpose:
N/A
Allocation:
N/A
Blinding:
N/A
Assignment:
N/A
Trial Arms:
1
Primary Outcome
- Patient ProfileTimeframe: At day of application
Secondary Outcome
- Dosing of Gadovist in different indicationsTimeframe: At time of application
- Adverse EventsTimeframe: Throughout and after application
Additional Information
Copyright © Bayer
Powered by
